BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
SUBSCRIBE
BullScope
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal
No Result
View All Result
BullScope
No Result
View All Result
Home Said vs. Filed

Lowe’s Narrows the Range: What the Call Revealed That the Filing Couldn’t Hide

Moe Alsumidaie, MBA, MSF by Moe Alsumidaie, MBA, MSF
August 20, 2026
in Said vs. Filed
0
74
SHARES
1.2k
VIEWS
Share on XShare on LinkedInShare on Facebook

For most of the past decade, Lowe’s has been a story of patient reinvention. The company spent years losing ground to Home Depot, then hired Marvin Ellison in 2018 and began a slow, methodical rebuild around professional contractors, supply-chain discipline, and digital sales. By fiscal 2023, the strategy looked like it was working: margins had climbed even as revenue fell, a rare combination that told investors the business was getting leaner, not just smaller. The question hanging over every earnings call since then has been whether that margin discipline could survive a housing market that simply refuses to thaw.

On August 19, 2026, Lowe’s gave its clearest answer yet, and it was not the one the guidance range had implied.

The moment the call turned

The sharpest exchange of the Q2 2026 earnings call came when analysts pressed management on the gap between the original full-year sales range and where the company now expects to land. CEO Marvin Ellison’s framing was careful: “Sustained growth in Pro, Online and Home Services led to our fifth consecutive quarter of positive comp sales, despite pressure in discretionary DIY spending.” The sentence is constructed to lead with the wins. But the filing tells you where the weight sits: the wins are real, and so is the pressure, and the pressure is winning on volume.

Back in February, when Lowe’s set its fiscal 2026 outlook, management projected a corridor of outcomes for total sales, comparable sales, and earnings per share. That range was affirmed again after the first-quarter call in May. Six weeks later, every number has been collapsed to its floor: the corridor is gone, replaced by a single point, and that point sits below what Wall Street had penciled in.

BullScope TerminalLowe was the article. The engine is the product.Same yardsticks, any ticker: filed financials in, math-vs-mood out. Nothing here is advice; it is the evidence, organized.Run another company →

What the numbers say

The math, meaning what the filed results actually show, tells a story of a business holding its margins tighter than its revenue. The mood, meaning what the market is currently paying, has already moved: the stock is down roughly a fifth over the past six months, trading just below where a decade of median valuations would place it. The open question is whether the guidance reset is a one-quarter clearing of the air or the beginning of a longer compression. Those two readings cannot both be right at once, and that disagreement is the story.

What the filing confirms, and what it complicates

The Q2 2026 press release shows total sales of $26.0 billion for the quarter ended July 31, 2026, with a gross margin of 33.0%. That margin is about eight-tenths of a percentage point below the same quarter last year. To put that in kitchen-table terms: for every $100 of lumber, paint, and appliances Lowe’s sold, it kept about 80 cents less after direct costs than it did a year ago. CFO Brandon Sink attributed the squeeze to acquisition dilution and elevated fuel and transportation costs, partially offset by a benefit from tariff refunds under the IEEPA program.

That tariff refund detail matters more than it sounds. The refund added a modest but meaningful lift to adjusted earnings per share in the quarter, which is part of why the reported result beat analyst estimates. But management explicitly excluded any further refunds from second-half guidance. So the beat was partly a one-time tailwind, and the guidance was written without it. JPMorgan analyst Christopher Horvers, as reported by TipRanks, highlighted the gap between the implied flat comp guidance for the second half of 2026 and prior Street expectations as a key disclosure from the call.

The Pro-versus-DIY fault line

Lowe’s has spent years trying to shift its customer mix toward professional contractors, the kind of buyers who return every week rather than every spring. That bet is paying off in the data: online sales grew at a double-digit pace in both the first and second quarters of fiscal 2026, and the Pro segment continues to outperform. But the DIY customer, a household deciding whether to finally redo the kitchen or replace the deck, is sitting on their hands. Fewer people came through the door in Q2, while the ones who did come spent more, likely on bigger, less deferrable projects.

That mix shift has a ceiling. Professional contractors are a smaller pool than the general public, and they follow housing starts. With mortgage rates still elevated and residential construction weak, even the Pro segment faces structural drag. Ellison’s framing on the call, “long-term fundamentals” and “strategic investments,” is the language of a management team asking for patience. The filing shows they’ve earned some of that patience: margins have held better than revenue, which is the harder trick. But patience has a price, and right now the market is discounting it.

BullScope TerminalWant the full evidence sheet behind pieces like this?The terminal runs the complete workup: Lowe and 500+ other names, on the same official data.See the evidence engine →

Inventory: the number that asks a question

One figure from the call deserves more attention than it received. Gurufocus, citing the earnings call highlights, noted that inventory rose by $1.4 billion from a year earlier, with management attributing roughly a third of that increase to acquisitions. The remainder is organic inventory growth in a quarter where comparable sales were essentially flat. A business building shelves faster than it empties them is either preparing for a demand surge it expects or managing a demand shortfall it hasn’t fully acknowledged. The filing cannot tell us which. The call did not resolve it either.

Analysts at DA Davidson, as reported by Benzinga, attributed the guidance reduction primarily to sales trends rather than margin deterioration, which is a meaningful distinction: the business is not falling apart at the cost line, it is simply selling less than hoped. That is a more recoverable problem, but only if demand returns.

Reading the numbers

Comparable store sales, Q2 2026: +0.2%. This measures sales at stores open at least a year, stripping out the effect of new locations. Think of it as the health of existing stores rather than the growth of the chain. A 0.2% gain means that for every $1,000 a store did in the same quarter last year, it did about $1,002 this year. Five consecutive positive quarters after a prolonged slump is genuinely meaningful, but the trend is decelerating, from 0.6% in Q1 to 0.2% in Q2.

Gross margin contraction of 80 basis points to 33.0%. Gross margin is what remains of each dollar of sales after the direct cost of the goods sold. An 80-basis-point drop means the margin fell by roughly eight-tenths of a percentage point. On $26 billion of quarterly sales, that translates to roughly $200 million less in gross profit than the prior-year margin rate would have produced, an amount larger than most companies earn in a year.

Adjusted EPS guidance for fiscal 2026: approximately $12.25. This is the company’s own estimate of earnings per share for the full year, adjusted to exclude certain one-time items. At the current stock price near $220, that implies a price-to-earnings multiple, the price tag per dollar of annual profit, of about 18 times. Our data puts the decade median at 18.6 times, so the stock is sitting just below its own historical average, neither obviously cheap nor obviously expensive, given a guidance range that has just been cut to a single point.

Sources

  • Lowe’s Q2 2026 earnings press release
  • Lowe’s Q2 2026 results announcement, August 19, 2026
  • Q2 2026 earnings call transcript via Biggo Finance
  • Lowe’s Q4 2025 results and initial FY2026 guidance, February 25, 2026
  • Lowe’s Q1 2026 earnings call transcript via The Motley Fool
  • Gurufocus Q2 2026 earnings call highlights
  • TipRanks on analyst reaction to Q2 2026 results
  • Benzinga on analyst forecast revisions, August 2026
  • 10-Q for quarter ended May 1, 2026 (SEC EDGAR)
  • 10-K for fiscal year ended January 30, 2026 (SEC EDGAR)
BullScope publishes impersonal research for a general audience. Nothing here is personalized investment advice, and nothing here is a recommendation to buy or sell any security. As of publication, neither BullScope nor its operator holds a position in any security, covered or otherwise; we do not trade at all, and we accept no compensation from any company we cover. When a conflict of interest exists, we do not publish: companies that compensate our operator in any capacity, or about which our operator could hold nonpublic information, are barred from coverage automatically, as described in the conflicts policy in our methodology. Figures come from company filings and public data through our published methodology; forecasts are conditional scenarios, not predictions and not promises. Markets carry risk, including loss of principal. Consider your own situation, or consult a licensed adviser, before acting on anything you read.
BullScope TerminalYou just read Lowe’s filed numbers.Every claim above traces to a filing. Run any of 500+ companies through the same math-vs-mood engine. Free tier available.Open the Terminal →
Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF

Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.

Recommended For You

Lilly’s Claims Ledger: What the Call Said, What the Filing Voted, What Held Up

by Moe Alsumidaie, MBA, MSF
August 7, 2026
0

In one breath Eli Lilly's Q2 2026 10-Q confirms revenue nearly doubling in two years, with two weight-loss drugs now generating almost two-thirds of every dollar the company...

Read moreDetails

Hill or Cliff? The One Exchange That Defines Merck Right Now

by Moe Alsumidaie, MBA, MSF
August 5, 2026
0

In one breath Merck's filed revenue is growing and its newest drugs are landing approvals, but two enormous acquisition charges have swallowed the headline profit number this year....

Read moreDetails

The Margin That Vanished: Meta’s Q2 Call vs. the Filed Record

by Moe Alsumidaie, MBA, MSF
August 5, 2026
0

In one breath Meta's revenue is growing faster than almost anyone expected. Its profit, for this quarter, is not. The company earned 28% more in Q2 2026 than...

Read moreDetails
Next Post

Evidence Sheet: Goldman Sachs Group (GS)

Please login to join discussion
BullScope
The Research Terminal
Run any stock through the BullScope evidence engine. Filings in, evidence out. Every number explains itself.
Open the Terminal
A BullScope product

Related News

The Weight of Expectations: Eli Lilly’s Filed Numbers vs. What the Market Is Paying

August 7, 2026

Apple at 97th Percentile: What the Price Already Believes

August 13, 2026

Boeing at $231: The Math Behind a Recovery Story the Market Has Already Priced

August 17, 2026
BullScope

BullScope is an evidence-first investment research publication. Every note starts in the filings: what companies actually report, what the market assumes, and where the two disagree. We read the numbers so you can read the story. Not investment advice.

Prefer BullScope.ai on Google

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

No Result
View All Result
  • Home
  • Market News
  • Bargains & Bubbles
  • Expectations Audits
  • Research Notes
  • Said vs. Filed
  • The Economy
  • Evidence Sheets
  • Research Terminal

© 2026 BullScope. Evidence-first investment research. Not investment advice.  ·  Methodology  ·  Privacy Policy  ·  Terms of Use  ·  Disclaimer

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.